Bionexus Gene Lab Stock Price History

BGLC Stock

USD 0.29 0 0.69%

Below is the normalized historical share price chart for BioNexus Gene Lab extending back to September 16, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioNexus Gene stands at 0.29, as last reported on the 22nd of November, with the highest price reaching 0.29 and the lowest price hitting 0.29 during the day.

IPO Date

16th of September 2020

200 Day MA

0.5278

50 Day MA

0.3853

Beta

1.866

Covid

If you're considering investing in BioNexus Stock, it is important to understand the factors that can impact its price. BioNexus Gene Lab secures Sharpe Ratio (or Efficiency) of -0.17, which signifies that the company had a -0.17% return per unit of risk over the last 3 months. BioNexus Gene Lab exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioNexus Gene's Mean Deviation of 2.7, risk adjusted performance of (0.09), and Standard Deviation of 3.5 to double-check the risk estimate we provide.

The current year's Issuance Of Capital Stock is expected to grow to about 6 M, whereas Other Stockholder Equity is forecasted to decline to (4.7 M). . At present, BioNexus Gene's Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 0.91, whereas Price To Sales Ratio is forecasted to decline to 0.82. BioNexus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1709

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns			BGLC

Estimated Market Risk

3.51

actual daily

69% of assets are more volatile

Expected Return

-0.6

actual daily

Most of other assets have higher returns

Risk-Adjusted Return

-0.17

actual daily

Most of other assets perform better

Based on monthly moving average BioNexus Gene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioNexus Gene by adding BioNexus Gene to a well-diversified portfolio.

Price Book

0.5742

Enterprise Value Ebitda

629.5269

Price Sales

0.587

Shares Float

13.8 M

Earnings Share

(0.06)

BioNexus Gene Stock Price History Chart

There are several ways to analyze BioNexus Stock price data. The simplest method is using a basic BioNexus candlestick price chart, which shows BioNexus Gene price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Highest Price	September 30, 2024	0.45
Lowest Price	November 18, 2024	0.29

BioNexus Gene November 22, 2024 Stock Price Synopsis

Various analyses of BioNexus Gene's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BioNexus Stock. It can be used to describe the percentage change in the price of BioNexus Gene from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BioNexus Stock.

BioNexus Gene Price Rate Of Daily Change

1.01

BioNexus Gene November 22, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in BioNexus Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use BioNexus Gene intraday prices and daily technical indicators to check the level of noise trading in BioNexus Stock and then apply it to test your longer-term investment strategies against BioNexus.

BioNexus Stock Price History Data

The price series of BioNexus Gene for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 has a statistical range of 0.17 with a coefficient of variation of 10.58. The prices are distributed with arithmetic mean of 0.39. The median price for the last 90 days is 0.4. The company had 1:12 stock split on 20th of July 2023.

	Open	High	Low	Close	Volume
11/22/2024	0.29	0.29	0.29	0.29
11/21/2024	0.30	0.30	0.29	0.29	32,439
11/20/2024	0.29	0.30	0.29	0.30	206,822
11/19/2024	0.31	0.31	0.28	0.29	107,700
11/18/2024	0.29	0.30	0.28	0.29	22,200
11/15/2024	0.32	0.32	0.28	0.30	58,550
11/14/2024	0.32	0.34	0.30	0.32	101,100
11/13/2024	0.33	0.34	0.32	0.32	54,200
11/12/2024	0.34	0.34	0.33	0.33	38,542
11/11/2024	0.35	0.35	0.32	0.34	174,000
11/08/2024	0.36	0.38	0.34	0.35	71,600
11/07/2024	0.36	0.38	0.34	0.36	193,000
11/06/2024	0.35	0.37	0.34	0.36	135,100
11/05/2024	0.37	0.38	0.36	0.36	31,200
11/04/2024	0.38	0.38	0.36	0.38	93,100
11/01/2024	0.36	0.38	0.36	0.38	58,000
10/31/2024	0.36	0.37	0.36	0.36	50,379
10/30/2024	0.38	0.38	0.36	0.36	98,400
10/29/2024	0.38	0.39	0.38	0.38	46,615
10/28/2024	0.38	0.38	0.37	0.38	15,400
10/25/2024	0.37	0.39	0.37	0.38	25,020
10/24/2024	0.37	0.39	0.36	0.39	58,600
10/23/2024	0.38	0.38	0.37	0.37	32,453
10/22/2024	0.36	0.39	0.35	0.38	199,700
10/21/2024	0.38	0.38	0.36	0.37	48,400
10/18/2024	0.37	0.38	0.37	0.37	88,700
10/17/2024	0.38	0.38	0.37	0.38	43,800
10/16/2024	0.39	0.39	0.37	0.39	14,600
10/15/2024	0.39	0.40	0.38	0.39	36,700
10/14/2024	0.38	0.40	0.38	0.39	126,800
10/11/2024	0.39	0.41	0.39	0.40	251,800
10/10/2024	0.41	0.43	0.41	0.42	129,700
10/09/2024	0.42	0.43	0.40	0.41	19,300
10/08/2024	0.43	0.43	0.41	0.43	27,000
10/07/2024	0.41	0.43	0.41	0.42	41,600
10/04/2024	0.44	0.45	0.40	0.42	25,200
10/03/2024	0.42	0.45	0.41	0.43	21,700
10/02/2024	0.44	0.46	0.41	0.43	51,900
10/01/2024	0.46	0.46	0.43	0.43	15,400
09/30/2024	0.45	0.46	0.44	0.45	55,200
09/27/2024	0.43	0.46	0.43	0.44	49,400
09/26/2024	0.42	0.47	0.42	0.43	399,800
09/25/2024	0.42	0.49	0.41	0.42	815,200
09/24/2024	0.42	0.43	0.40	0.42	59,500
09/23/2024	0.42	0.45	0.42	0.42	84,800
09/20/2024	0.43	0.43	0.40	0.40	110,000
09/19/2024	0.44	0.44	0.42	0.42	49,800
09/18/2024	0.43	0.45	0.42	0.42	63,100
09/17/2024	0.49	0.49	0.43	0.43	326,200
09/16/2024	0.40	0.46	0.40	0.44	945,000
09/13/2024	0.39	0.46	0.39	0.40	1,749,456
09/12/2024	0.35	0.58	0.34	0.39	12,422,600
09/11/2024	0.36	0.49	0.34	0.36	2,352,800
09/10/2024	0.39	0.39	0.34	0.35	126,672
09/09/2024	0.39	0.41	0.37	0.38	115,100
09/06/2024	0.41	0.44	0.39	0.41	272,017
09/05/2024	0.44	0.44	0.42	0.42	13,100
09/04/2024	0.43	0.44	0.42	0.43	9,800
09/03/2024	0.46	0.46	0.42	0.42	75,800
08/30/2024	0.43	0.46	0.41	0.44	60,900
08/29/2024	0.46	0.46	0.43	0.44	51,106

About BioNexus Gene Stock history

BioNexus Gene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioNexus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioNexus Gene Lab will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioNexus Gene stock prices may prove useful in developing a viable investing in BioNexus Gene

	Last Reported	Projected for Next Year
Common Stock Shares Outstanding	15.9 M	12.1 M
Net Income Applicable To Common Shares	864.3 K	907.5 K

BioNexus Gene Quarterly Net Working Capital

6.44 Million

BioNexus Gene Stock Technical Analysis

BioNexus Gene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.

Volatility Indicators

View

Value Movement

View

A focus of BioNexus Gene technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BioNexus Gene trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Price Ceiling Movement Now

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments

All Next

Launch Module

BioNexus Gene Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for BioNexus Gene's price direction in advance. Along with the technical and fundamental analysis of BioNexus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioNexus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for BioNexus Stock analysis

When running BioNexus Gene's price analysis, check to measure BioNexus Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNexus Gene is operating at the current time. Most of BioNexus Gene's value examination focuses on studying past and present price action to predict the probability of BioNexus Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNexus Gene's price. Additionally, you may evaluate how the addition of BioNexus Gene to your portfolios can decrease your overall portfolio volatility.

	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Stocks Directory Find actively traded stocks across global markets
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

	Risk Adjusted Performance	(0.09)
	Jensen Alpha	(0.50)
	Total Risk Alpha	(0.85)
	Treynor Ratio	(1.02)

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Bionexus Gene Lab Stock Price History

Sharpe Ratio = -0.1709

Estimated Market Risk

Expected Return

Risk-Adjusted Return

BioNexus Gene Stock Price History Chart

BioNexus Gene November 22, 2024 Stock Price Synopsis

BioNexus Gene November 22, 2024 Stock Price Analysis

BioNexus Stock Price History Data

About BioNexus Gene Stock history

BioNexus Gene Quarterly Net Working Capital

6.44 Million

BioNexus Gene Stock Technical Analysis

Did you try this?

Run Price Ceiling Movement Now

Price Ceiling Movement

BioNexus Gene Technical and Predictive Indicators

Complementary Tools for BioNexus Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY